Your session is about to expire
← Back to Search
Beta Blocker
Vascular Effects of Carvedilol Versus Metoprolol in Hypertensive Patients With Type 2 Diabetes
Phase 4
Waitlist Available
Led By Alan J Bank, M.D.
Research Sponsored by St. Paul Heart Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to 5 months
Awards & highlights
Approved for 10 Other Conditions
Pivotal Trial
No Placebo-Only Group
All Individual Drugs Already Approved
Drug Has Already Been Approved
Summary
The purpose of this study is to compare the vascular effects of two commonly used blood pressure medications, carvedilol and metoprolol in hypertensive patients with type 2 diabetes.
Eligible Conditions
- Diabetes
- High Blood Pressure
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change from baseline to 5 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to 5 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Flow Mediated Dilation
Awards & Highlights
Approved for 10 Other Conditions
This treatment demonstrated efficacy for 10 other conditions.
Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
Drug Has Already Been Approved
The FDA has already approved this drug, and is just seeking more data.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: CarvedilolExperimental Treatment1 Intervention
Carvedilol, orally, 25 mg, twice daily for five months
Group II: MetoprololActive Control1 Intervention
Metoprolol, orally, 200 mg, twice daily for five months.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Carvedilol
FDA approved
Find a Location
Who is running the clinical trial?
St. Paul Heart ClinicLead Sponsor
4 Previous Clinical Trials
211 Total Patients Enrolled
GlaxoSmithKlineIndustry Sponsor
4,815 Previous Clinical Trials
8,384,154 Total Patients Enrolled
Alan J Bank, M.D.Principal InvestigatorSt. Paul Heart Clinic
1 Previous Clinical Trials
36 Total Patients Enrolled